Table 1.
SNPs Associated at p < 10−5 with VT in the GWAS Scan and Their Replication in the Independent MARTHA and FARIVE Studies
Chr. | Gene(s) | rsID | Position | Alleles |
GWAS |
MARTHA |
FARIVE |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MAFa |
p Valueb |
MAFa |
p Valueb |
MAFa |
p Valueb | ||||||||
Controls (n = 1228) | Cases (n = 419) | Controls (n = 801) | Cases (n = 1129) | Controls (n = 607) | Cases (n = 607) | ||||||||
1p34.2 | PTPRF | rs11210892 | 43 872 671 | A/G | 0.32 | 0.40 | 6.70 × 10−6 | 0.32 | 0.37 | 1.83 × 10−3 | 0.33 | 0.33 | 0.811 |
3q26.31 | TNIK | rs10936688 | 172 656 249 | A/G | 0.36 | 0.44 | 3.15 × 10−6 | 0.39 | 0.37 | 0.187 | |||
6p24.1 | HIVEP1 | rs169713 | 12 028 503 | T/C | 0.21 | 0.28 | 7.24 × 10−6 | 0.23 | 0.29 | 2.08 × 10−5 | 0.21 | 0.24 | 0.089 |
rs9380643 | 12 038 473 | C/T | 0.22 | 0.30 | 2.44 × 10−6 | 0.24 | 0.31 | 1.98 × 10−6 | 0.24 | 0.26 | 0.227 | ||
7p15.3 | IL6/TOMM7 | rs10229457 | 22 767 325 | G/A | 0.29 | 0.38 | 1.05 × 10−6 | 0.34 | 0.36 | 0.128 | - | - | - |
8p21.3 | ATP6V1B2/LZTS1 | rs952148 | 20 135 799 | C/T | 0.11 | 0.06 | 1.35 × 10−6 | 0.10 | 0.11 | 0.459 | - | - | - |
12p12.1 | ST8SIA1 | rs2268861 | 22 280 741 | G/A | 0.32 | 0.24 | 1.82 × 10−6 | 0.31 | 0.29 | 0.231 | - | - | - |
16q22.1 | NFATC3 | rs12598 | 66 783 016 | G/A | 0.08 | 0.04 | 7.64 × 10−6 | 0.06 | 0.05 | 0.074 | - | - | - |
22q13.31 | Gene desert | rs4823511 | 46 823 885 | A/G | 0.24 | 0.16 | 5.45 × 10−6 | 0.22 | 0.21 | 0.421 | - | - | - |
SNPs that did not pass the genome-wide significance level of 1.71 × 10−7 but showed suggestive evidence of association (p < 10−5) were investigated in the MARTHA study. SNPs that passed the Bonferroni-corrected significance level (p < 5.6 × 10−3) in MARTHA were further tested for association with VT in FARIVE.
MAF, minor allele frequency.
p values of the Cochran-Armitage trend test.